Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Monomethyl Fumarate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,929Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cycle Pharma Acquires Banner Life Sciences, LLC
    Cycle Pharma Acquires Banner Life Sciences, LLC

    13 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250113852731/en

    BUSINESSWIRE
    13 Jan 2025
    Share Share
    European Commission grants marketing authorisation for Vumerity
    European Commission grants marketing authorisation for Vumerity

    17 Nov 2021

    // Anna Begley EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/news/165570/european-commission-grants-marketing-authorisation-for-vumerity/

    Anna Begley EUROPEANPHARMACEUTICALREVIEW
    17 Nov 2021
    Share Share
    Banner Life Sciences Announces BAFIERTAM, a Novel Oral Fumarate Treatment
    Banner Life Sciences Announces BAFIERTAM, a Novel Oral Fumarate Treatment

    03 Sep 2020

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/banner-life-sciences-announces-bafiertam-a-novel-oral-fumarate-treatment-1600067525.pdf

    PRESS RELEASE
    03 Sep 2020
    Share Share
    Banner Life Sciences Announces Commercial Launch of BAFIERTAM
    Banner Life Sciences Announces Commercial Launch of BAFIERTAM

    16 Jul 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200716006004/en

    BUSINESSWIRE
    16 Jul 2020
    Share Share
    Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for MS
    Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for MS

    01 May 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200430005256/en/Banner-Life-Sciences-Announces-Final-FDA-Approval

    BUSINESSWIRE
    01 May 2020
    Share Share
    Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for MS
    Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for MS

    30 Apr 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200430005256/en

    BUSINESSWIRE
    30 Apr 2020
    Share Share